The New York-based 2nd U.S. Circuit Court of Appeals said Cognizant was not entitled to the damages under the federal trade secret law andThe court, however, affirmed that Syntel was liable for misusing the trade secrets that belonged to Cognizant's TriZetto Healthcare.
Cognizant countersued Syntel for taking trade secrets related to its Facets software, used by healthcare insurance companies to automate administrative tasks, during its work with TriZetto and using them to develop a competing product. The 2nd Circuit affirmed Thursday that Syntel was liable for misappropriating more than 100 Cognizant trade secrets. But it took issue with the legal theory that had justified Cognizant's damages.
"TriZetto's valuable trade secrets are still that—valuable and secret," U.S. Circuit Judge Richard Wesley wrote for a three-judge panel.